Opyl (ASX:OPL) Capital Expenditure : A$-0.00 Mil (TTM As of Dec. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Opyl Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Opyl's cash flow for capital expenditures for the six months ended in Dec. 2024 was A$-0.00 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Dec. 2024 was A$-0.00 Mil.

Opyl Capital Expenditure Historical Data

The historical data trend for Opyl's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Opyl Capital Expenditure Chart

Opyl Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Capital Expenditure

Get a 7-Day Free Trial

-0.07

-0.01

-0.02

Opyl Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Capital Expenditure	Get a 7-Day Free Trial															-	-	-	-	-

Opyl Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.00 Mil.

Opyl Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Opyl Ltd (ASX:OPL) » Definitions » Capital Expenditure

Comparable Companies

Traded in Other Exchanges

N/A

Address

6 Middlemiss Street, Milsons Point, Sydney, NSW, AUS, 2000

Website

https://www.opyl.ai

Opyl Ltd is engaged in the development of its digital tools that improve clinical trials, healthcare experience for patients, deliver deep market insights from social media data, and improve the efficiency and value of the clinical research process. It invests in research and develops technologies as well as provides digital tools and insights services to healthcare, wellness, and science technology-focused clients.

Opyl Headlines

No Headlines